Palatin Technologies (PTN) Gross Margin (2019 - 2024)
Palatin Technologies' (PTN) quarterly Gross Margin came in at 100.0% in Q2 2024, up 590.0% on a YoY basis from 14.49% in Q3 2023, and up 5.04% quarter-over-quarter from 95.2% in Q4 2023.
Powered by 
Analysis
Palatin Technologies (PTN) Gross Margin (2019 - 2024) Analysis & Trends
Palatin Technologies (PTN) has reported Gross Margin for 6 consecutive years, with 100.0% the latest figure, recorded in Q2 2024.
- For the quarter ending Q2 2024, Gross Margin rose 590.0% year-over-year to 100.0%; the trailing twelve-month figure through Mar 2025 stood at 100.0% (up 342.0% YoY), and the FY2024 full-year result was 97.83%, up 645.0% from the prior year.
- Gross Margin advanced to 100.0% in Q2 2024 per PTN's latest filing, from 95.2% in the prior quarter.
- Across five years, Gross Margin topped out at 146.95% in Q2 2021 and bottomed at 37.53% in Q1 2021.
- Historically, Gross Margin has averaged 89.39% across 5 years, with a median of 90.38% in 2022.
- The widest YoY moves for Gross Margin: up 4077 bps in 2022, down 5831 bps in 2022.
- Over 5 years, Gross Margin stood at 82.07% in 2020, then gained by 11 bps to 90.94% in 2021, then declined by 1 bps to 90.38% in 2022, then rose by 5 bps to 95.2% in 2023, then rose by 5 bps to 100.0% in 2024.
- According to Business Quant data, Gross Margin over the past three periods registered 100.0%, 95.2%, and 100.0% for Q2 2024, Q4 2023, and Q3 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 72.04% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 79.76% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 85.33% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 91.59% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 90.43% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 35.86% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 76.90% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 71.60% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 80.31% |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 100.00% |
| Dec 31, 2023 | 95.20% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 94.10% |
| Mar 31, 2023 | 89.19% |
| Dec 31, 2022 | 90.38% |
| Sep 30, 2022 | 90.05% |
| Jun 30, 2022 | 88.65% |
| Mar 31, 2022 | 78.29% |
| Dec 31, 2021 | 90.94% |
| Sep 30, 2021 | 66.18% |
| Jun 30, 2021 | 146.95% |
| Mar 31, 2021 | 37.53% |
| Dec 31, 2020 | 82.07% |
| Sep 30, 2020 | 91.27% |
| Dec 31, 2019 | 100.00% |
| Sep 30, 2019 | 100.00% |